Current Molecular Medicine
Title:Editorial (Hot Topic: Signaling in Cell Death, Survival, Proliferation and Degeneration)
Volume: 13 Issue: 2
Author(s): S. S. Smaili, A. F. G. Quest, C. Hetz and Sergio Lavandero
Affiliation:
Export Options
About this article
Cite this article as:
Smaili S. S., G. Quest F. A., Hetz C. and Lavandero Sergio, Editorial (Hot Topic: Signaling in Cell Death, Survival, Proliferation and Degeneration), Current Molecular Medicine 2013; 13 (2) . https://dx.doi.org/10.2174/1566524011313020001
DOI https://dx.doi.org/10.2174/1566524011313020001 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proline Oxidase (POX) as A Target for Cancer Therapy
Current Drug Targets Targeting Angiogenesis in Head and Neck Cancer
Current Cancer Drug Targets Solvent-Free Synthesis of New 3’H-spiro[indole-3,2’-[1,3]]benzothiazole- 2(1H)-one Derivatives Using Michael Reaction
Letters in Organic Chemistry FtsZ: A Novel Target for Tuberculosis Drug Discovery
Current Topics in Medicinal Chemistry Polyphenols and Cardiovascular Disease: A Critical Summary of the Evidence
Mini-Reviews in Medicinal Chemistry Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
Current Topics in Medicinal Chemistry Fine-tuning of microRNAs in Type 2 Diabetes Mellitus
Current Medicinal Chemistry Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Current Vascular Pharmacology Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides
Current Pharmaceutical Biotechnology Mechanisms of ERK1/2 Regulation by Seven-Transmembrane-Domain Receptors
Current Pharmaceutical Design Editorial (Hot Topic: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products)
Anti-Cancer Agents in Medicinal Chemistry Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
CNS & Neurological Disorders - Drug Targets Mechanisms of Resistance to Chemotherapy in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Recent Patents on Bacterial Proteins as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Effect of Non-Steroidal Anti-Inflammatory Drugs on Bone Turnover: An Evidence-Based Review
Reviews on Recent Clinical Trials Indole-3-Acetic Acids and Horseradish Peroxidase: A New Prodrug / Enzyme Combination for Targeted Cancer Therapy
Current Pharmaceutical Design Combination Therapy with Arsenic Trioxide for Hematological Malignancies
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Vaccines for Cervical Cancer: Dendritic Cell-Based Immunotherapy
Current Pharmaceutical Design Targeting Trail Towards the Clinic
Current Drug Targets Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Current Pharmaceutical Design